Company News
-
Jointly Exploring New Paths for TCM Modernization | Chairman Gong Hongjia of Jiadao Capital and His Entourage Visit Yineng Pharmaceutical for Inspection and Exchange
On November 2nd, Gong Hongjia, Chairman of Jiadao Capital, led his team to visit Hunan Yineng Biopharmaceutical Co., Ltd. (hereinafter referred to as “Yineng Pharmaceutical”) for inspection and exchange, aiming to conduct an in-depth exploration of the innovative practices and develop...Read more -
Good News | Yineng Pharmaceutical’s Class 3.1 New TCM Drug – Classic Formula Linggui Zhugan Decoction Granules – Approved for Marketing
Recently, Hunan Yineng Biopharmaceutical Co., Ltd. (hereinafter referred to as “Yineng Pharmaceutical”) has received the Drug Registration Certificate for Linggui Zhugan Decoction Granules approved and issued by the National Medical Products Administration (NMPA). The product has been...Read more -
Happy New Year! 2026
The start of 2026 is a moment to reflect—and to look ahead with hope. We are grateful for the opportunity to serve you in 2025 and eager to grow together in the year to come. Thank you for your partnership. May 2026 bring you strength, innovation, and lasting success.Read more -
One road forward, new stars shine! MedGence 2023 new staff training camp successfully concluded!
The year when the Fuyao, the star bit the moon day by day light! Every new person is the core power of the company's development, in this charming summer, Easy medicine ushered in a large number of dreams of young people, they are energetic, they are energetic, in order ...Read more -
MedGence was honored as one of the “2023 Top 20 R&D CRO Enterprises in China”!
On June 16-17, 2023, MedGence participated in the Conference on High-Quality Development of Healthcare Industry & the 8th Summit for China Pharmaceutical R&D Innovation, which was held successfully in Chongqing. MedGence was honored as one of the "2023 Top 20 R&a...Read more -
MedGence Talks on Clinical Trials of Traditional Chinese Medicines｜Guangzhou Huizhi Successful Drug Research Co., Ltd.
In the afternoon of June 14th, the general manager of Guangzhou Huizhi Successful Drug Research Co. (hereinafter referred to as "EnOcean Pharmaceuticals"), accompanied by Dr. Yi Yuneng, Chairman and General Manager of EnOcean Pharmaceuticals, Prof. Jin Yi, Chief Scientis...Read more -
Sincere Cooperation – Signing Ceremony of over 100 million RMB Financing for MedGence was successfully held
On the morning of March 30, MedGence, Guangdong Traditional Chinese Medicine Fund (TCMHF) and Hygeia Capital signed an investment agreement of over 100 million yuan together in Changsha, Hunan. This round of financing was led by Guangdong TCM Great Health Fund, with Wyge...Read more
